Sayed Mohamed S

Sebhat Aron M, Sarhan Hashem Abu, Alfatih Muhammad, Hidad Adam G, Aref Ahmad A, Sayed Mohamed S et al.

Ayoubi Mohammad, Sayed Mohamed S, Khodeiry Mohamed M, Elhusseiny Abdelrahman M, Lee Richard K

Big data in ophthalmology, using diverse databases, is transforming research by enabling AI, uncovering systemic links, and improving precision medicine for glaucoma and other conditions.

Sayed Mohamed S, Ayoubi Mohammad, Khodeiry Mohamed M, Elhusseiny Abdelrahman M, Lee Richard K

Khodeiry Mohamed M, Yusuf Ramsey, Dorizas Christopher A, Elhusseiny Abdelrahman M, Sayed Mohamed S, Ruan Merry et al.

SC-TSCPC effectively lowers IOP in pseudoexfoliation glaucoma, offering a relatively safe, repeatable treatment option for medically uncontrolled cases, though further study is warranted.

Elhusseiny Abdelrahman M, Khaled Omar M, Chauhan Muhammad Z, Sayed Mohamed S, Shaarawy Tarek

This study compared Paul vs. Ahmed glaucoma implants in refractory childhood glaucoma, finding both devices comparably effective and safe at one year, offering similar treatment options.

Chen Jessica L, Elhusseiny Abdelrahman M, Khodeiry Mohamed M, Smith Michael P, Sayed Mohamed S, Banitt Michael et al.

This study found that in complex glaucoma cases, corneal graft failure after GDI and PK is more common than GDI failure, implying IOP control isn't the sole determinant of graft survival.

Elhusseiny Abdelrahman M, Khodeiry Mohamed M, Liu Xiangxiang, Sayed Mohamed S, Lee Richard K

Slow-coagulation CW-TSCPC effectively lowered IOP and medication use in medically uncontrolled secondary aphakic glaucoma, offering a safe, non-incisional initial surgical option with a 63.4% success rate at one year.

Khodeiry Mohamed, Sayed Mohamed S

New glaucoma drainage devices show promising initial results, comparable to traditional implants, potentially offering easier insertion and better outcomes for complex glaucoma patients.

Khodeiry Mohamed M, Lauter Alison J, Sayed Mohamed S, Han Ying, Lee Richard K

Slow-coagulation TSCPC effectively lowered IOP and reduced medications in medically uncontrolled neovascular glaucoma, showing it's a safe and viable initial treatment option.

Khodeiry Mohamed M, Liu Xiangxiang, Sheheitli Huda, Sayed Mohamed S, Lee Richard K

Slow coagulation TSCPC effectively and safely lowered intraocular pressure in patients with silicone oil-induced glaucoma, making it a viable initial surgical option with minimal complications.

Khodeiry Mohamed M, Sheheitli Huda, Sayed Mohamed S, Persad Patrice J, Feuer William J, Lee Richard K

Slow coagulation TSCPC effectively lowered IOP and medication use in pseudophakic glaucoma patients, especially with higher baseline IOP, showing good safety as an initial treatment.

Alawa Karam AlRahman, Nolan Ryan P, Han Elaine, Arboleda Alejandro, Durkee Heather, Sayed Mohamed S et al.

A smartphone-based glaucoma visual field test (MVP FDT) was comparable to standard, expensive equipment. This offers a low-cost, portable, and accessible screening tool for glaucoma.

Sayed Mohamed S, Lee Richard K

This abstract reviews XFG surgical options, finding cataract surgery significantly lowers IOP and may prevent glaucoma, while newer MIGS and non-penetrating surgeries are emerging, expanding treatment choices.

Sayed Mohamed S, Margolis Michael, Lee Richard K

OCT's "green" (normal) labels can falsely reassure clinicians, masking early glaucoma or progression. Awareness of this "green disease" is crucial for accurate diagnosis and management.